| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Tafluprost 15 microgram/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tafluprost (substance) |
Inferred relationship |
Some |
|
| Product containing tafluprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
1 |
| Tafluprost 15 microgram/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
1 |
| Tafluprost 15 microgram/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing tafluprost in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing only tafluprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing only tafluprost in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tafluprost 15 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely tafluprost 15 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
2 |
| Product containing tafluprost and timolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
2 |
| Product containing only tafluprost and timolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
2 |
| Tafluprost- and timolol-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
2 |
| Product containing only tafluprost and timolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tafluprost (substance) |
Inferred relationship |
Some |
2 |
FHIR